IV Haloperidol for the Treatment of Headache in the ED
Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
Single center, double-blind, randomized, placebo-controlled trial evaluating analog pain
scores in patients who present to the emergency department (ED) with a complaint of headache.
A total of 150 patients age 13-55 presenting to the emergency department with headache will
be enrolled from October 2015 - October 2016. Patients will be randomized and pain scores and
side effects will be recorded at 0, 30, 60, and 90 minutes. Follow-up will be performed by
telephone at 24 hours.